Sidley Global Life Sciences’ Post

A few quick thoughts from JPM on areas of likely further #lifesciences deal-making in 2025.

Texas Health Catalyst identifies promising health and life sciences innovation and propels it toward real-world impact — and its latest call for proposals is now open! Learn about this cycle's challenges for targeted @UTAustin innovation: https://bit.ly/4eNWCC5

Texas Health Catalyst identifies promising health and life sciences innovation and propels it toward real-world impact — and its latest call for proposals is now open! Learn about this cycle's challenges for targeted @UTAustin innovation: https://bit.ly/4eNWCC5

The breadth and depth of cutting-edge science at the 1st Helmholtz Health Summit (https://lnkd.in/dtC68rET) was truly amazing! …and should be even more recognized by the public, by policy makers, by industry, and by investors. It also became apparent once more that the major challenge in Germany and Europe remains systematic and rapid translation & transfer of this cutting edge science into tangible outcomes, applications and products for our patients. This requires new formats and initiatives for academia and industry to work hand in hand, translational KPIs other than only judging scientific outputs on publications, and training opportunities for next-generation researchers to foster entrepreneurship and carreer opportunities in this space!

European countries and the EU need a collaborative effort to create a stronger long term vision for how its life science eco system should develop. This is one of the key recommendations in the ‘Attracting Life Science Investments in Europe’ report - an initiative of the BioMed Alliance, EuropaBio and Johnson & Johnson. The size and importance of life science in Europe demands dedicated strategies with a long term perspective, to support the health and wellbeing of patients, and the economy. This report is a debate starter. The findings provide each of the 22 countries included with an understanding of their strengths and weaknesses, and can be used as a basis for open debate and constructive discussions with stakeholders and policymakers interested in attracting life science investment to their country.

 We hope that countries will use it to identify opportunities, commence a debate at national level about what their long term life science vision should be, and ensure that policies are put in place to enable that vision to be realised.

 To discover what the report is about, see here: https://bit.ly/3Umpgmn Invested in hEUman health #EUInvestsinLife #LifeSciences

Queensland Global Connector Dr Scott Patterson (Ph.D.) joined the TIQ North America team in welcoming Queensland life science delegates to the J.P. Morgan Healthcare Conference in San Francisco this week. Dr Patterson, who has had a remarkable career in life sciences in North America, offered words of encouragement and guidance to the cohort. TIQ is working alongside Dr Patterson to position Queensland as an ideal destination for biomedical and life science investment, clinical trials and research partnerships. Together with the Brisbane Economic Development Agency, TIQ is supporting more than 20 delegates at JPM 2025 to raise capital and align with strategic partners. Learn more about Queensland's thriving biomedical and life sciences sector https://lnkd.in/gnFxy-gk Viki Forrest | Alita Singer | Hanna Peltonen | Gabe Sulkes | David Brown

Parexel are proud to be part of the eCOA Consortium and to share knowledge in a pre-competitive space. This article, in collaboration between Elena Izmailova, Danielle M., Reem Yunis, PhD, Julia Lakeland, Kristen Sowalsky, PhD, DC, Alison Ritchie, Christine Cong Guo and Bill Byrom, examines the scientific considerations for sensor-based DHT implementation. Next up: the operational considerations! Read the first article here:

Just completed week 1 of the short course on *Laboratory Systems and Public Health in Low Resource Settings (Lab-Sphere)* at the Bernhard Nocht Institute for Tropical Medicine (BNITM), in Hamburg, Germany and the experience has been truly transformative! 🌍🔬 The hands-on sessions and collaborative discussions are pushing my **problem-solving** and **critical thinking** skills to new levels, particularly in addressing real-world challenges faced by public health labs in low-resource environments. Making **quick, informed decisions** in such contexts is essential, and the course is giving me practical tools to approach these issues effectively. Highly excited to apply the new skills to back home and continue learning from the experts and my peers. #BNITM #LabSphere #PublicHealth #LaboratorySystems #LowResourceSettings #CriticalThinking #ProblemSolving #GlobalHealth #CapacityBuilding #QuickDecisionMaking

Looking forward to an interesting discussion later at the BE News 'Spotlight on Life Sciences' event this evening. There will no doubt be some really interesting perspectives across the keynotes and panel on the scalability and potential to unlock opportunities in this most innovative of sectors. Carter Jonas #lifescience #scienceandtechnology #innovation

🏥🗞️BIG NEWS: In its first year, Advanced Research Projects Agency for Health (ARPA-H) delivered nearly $300M to Massachusetts! With world-class research institutions, life science companies, and medical centers, there’s no better place for health care innovation than right here in the Bay State. Read more: https://lnkd.in/epscvXzr